featured
Safety and Benefit–Risk Profile of Biologics and Oral Treatments for Moderate-to-Severe Plaque Psoriasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Comparative Safety and Benefit-Risk Profile of Biologics and Oral Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-Analysis of Clinical Trial Data
J Am Acad Dermatol 2021 Feb 22;[EPub Ahead of Print], NH Shear, KA Betts, AM Soliman, A Joshi, Y Wang, J Zhao, P Gisondi, R Sinvhal, AW ArmstrongFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.